# Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/three-times-weekly-dosing-of-daprodustat-versus-conventional-epoetin-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Daniel W. Coyne,Ajay Singh,Renato D. Lópes,Christine K. Bailey,Tara DiMino,Chun Huang,Jeffrey J. Connaire,Anjay Rastogi,Sung-Gyun Kim,Marcelo Orías,Sapna Shah,Vickas Patel,Alexander R. Cobitz,Christoph Wanner |
| Citations | 39 |
| DOI | 10.2215/cjn.00550122 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/9625096 |
| OpenAlex ID | https://openalex.org/W4289785769 |
| PMID | 35918106 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Sapna Shah](https://scholariq.org/researchers/sapna-shah/)

## Paper journal

- [Clinical Journal of the American Society of Nephrology](https://scholariq.org/journals/clinical-journal-of-the-american-society-of-nephrology/)

## Paper primary topic

- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)

## Paper topics

- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.